1
|
Qu B, Lee J, Wu L, Saha AK, Li G, Xu Y, Tan Z, Brazzillo J, Haddad N, Pennino S, Rodriguez S, Lorenz JC, Frutos R, Sidhu KPS, Wang XJ, Zhang Y, Senanayake CH, Song JJ. Scalable Process of Spiro(cyclopropane)oxazepane Pyridine Carboxylic Acid through Kulinkovich, Mitsunobu, and Pd-Catalyzed Intramolecular C–N Coupling. Org Process Res Dev 2022. [DOI: 10.1021/acs.oprd.2c00221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Bo Qu
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Jaehee Lee
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Lifen Wu
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Anjan K. Saha
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Guisheng Li
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Yibo Xu
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Zhulin Tan
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Jason Brazzillo
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Nizar Haddad
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Scott Pennino
- Material and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Sonia Rodriguez
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Jon C. Lorenz
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Rogelio Frutos
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Kanwar P. S. Sidhu
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Xiao-Jun Wang
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Yongda Zhang
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Chris H. Senanayake
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Jinhua J. Song
- Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| |
Collapse
|
2
|
Tamboli Y, Kashid BB, Yadav RP, Rafeeq M, Yeole R, Merwade AY. Triphenylphosphine Oxide Removal from Reactions: The Role of Solvent and Temperature. ACS OMEGA 2021; 6:13940-13945. [PMID: 34095685 PMCID: PMC8173612 DOI: 10.1021/acsomega.1c01996] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/19/2021] [Accepted: 05/11/2021] [Indexed: 06/12/2023]
Abstract
Here, a large-scale feasible, chromatography-free process to purge triphenylphosphine oxide (TPPO) from the crude product of Mitsunobu and Wittig reactions has been developed. Divergence in physicochemical properties like polarity and solubility of TPPO against the product was utilized to precipitate TPPO directly from the reaction mixture and eliminate by simple filtration on a kilogram scale at a pilot plant with high purity of the product.
Collapse
Affiliation(s)
- Yasinalli Tamboli
- Chemical
Research, Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad 431 006, India
| | - Bharat B. Kashid
- Chemical
Research, Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad 431 006, India
| | - Ram Prasad Yadav
- Chemical
Research, Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad 431 006, India
| | - Mohammad Rafeeq
- Chemical
Research, Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad 431 006, India
| | - Ravindra Yeole
- Department
of Analytical Chemistry, Wockhardt Research
Centre, D-4, MIDC, Chikalthana, Aurangabad 431 006, India
| | - Arvind Y. Merwade
- Chemical
Research, Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad 431 006, India
| |
Collapse
|
3
|
Li B, Li R, Dorff P, McWilliams JC, Guinn RM, Guinness SM, Han L, Wang K, Yu S. Deprotection of N-Boc Groups under Continuous-Flow High-Temperature Conditions. J Org Chem 2019; 84:4846-4855. [PMID: 30620880 DOI: 10.1021/acs.joc.8b02909] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
The scope of thermolytic, N-Boc deprotection was studied on 26 compounds from the Pfizer compound library, representing a diverse set of structural moieties. Among these compounds, 12 substrates resulted in clean (≥95% product) deprotection, and an additional three compounds gave ≥90% product. The thermal de-Boc conditions were found to be compatible with a large number of functional groups. A combination of computational modeling, statistical analysis, and kinetic model fitting was used to support an initial, slow, and concerted proton transfer with release of isobutylene, followed by a rapid decarboxylation. A strong correlation was found to exist between the electrophilicity of the N-Boc carbonyl group and the reaction rate.
Collapse
Affiliation(s)
- Bryan Li
- Medicinal Science, Worldwide Research and Development , Pfizer Inc. , Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Ruizhi Li
- Medicinal Science, Worldwide Research and Development , Pfizer Inc. , Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Peter Dorff
- Medicinal Science, Worldwide Research and Development , Pfizer Inc. , Eastern Point Road , Groton , Connecticut 06340 , United States
| | - J Christopher McWilliams
- Medicinal Science, Worldwide Research and Development , Pfizer Inc. , Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Robert M Guinn
- Medicinal Science, Worldwide Research and Development , Pfizer Inc. , Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Steven M Guinness
- Medicinal Science, Worldwide Research and Development , Pfizer Inc. , Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Lu Han
- Medicinal Science, Worldwide Research and Development , Pfizer Inc. , Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Ke Wang
- Medicinal Science, Worldwide Research and Development , Pfizer Inc. , Eastern Point Road , Groton , Connecticut 06340 , United States
| | - Shu Yu
- Medicinal Science, Worldwide Research and Development , Pfizer Inc. , Eastern Point Road , Groton , Connecticut 06340 , United States
| |
Collapse
|
4
|
Fukuda T, Hara T, Ina S, Nemoto T, Oshima T. Development of a Synthetic Process for K-8986, an H1-Receptor Antagonist. Org Process Res Dev 2019. [DOI: 10.1021/acs.oprd.8b00380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Tomoaki Fukuda
- Tokyo New Drug Research Laboratories, Pharmaceutical Division, Kowa Company, Ltd., 2-17-43, Noguchicho, Higashimurayama, Tokyo 189-0022, Japan
- Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba 260-8675, Japan
| | - Takeaki Hara
- Tokyo New Drug Research Laboratories, Pharmaceutical Division, Kowa Company, Ltd., 2-17-43, Noguchicho, Higashimurayama, Tokyo 189-0022, Japan
| | - Shinji Ina
- Tokyo New Drug Research Laboratories, Pharmaceutical Division, Kowa Company, Ltd., 2-17-43, Noguchicho, Higashimurayama, Tokyo 189-0022, Japan
| | - Tetsuhiro Nemoto
- Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba 260-8675, Japan
| | - Takeshi Oshima
- Tokyo New Drug Research Laboratories, Pharmaceutical Division, Kowa Company, Ltd., 2-17-43, Noguchicho, Higashimurayama, Tokyo 189-0022, Japan
| |
Collapse
|
5
|
Hopes P, Langer T, Millard K, Steven A. Decoration of an α-Resorcylate Nucleus as Part of the Manufacture of a Glucokinase Activator. Org Process Res Dev 2018. [DOI: 10.1021/acs.oprd.8b00175] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Phillip Hopes
- Cyton Biosciences Ltd., 68 Macrae Road, Bristol, BS20 0DD, United Kingdom
| | - Thomas Langer
- Pharmaceutical Technology & Development, AstraZeneca, Charter Way, Macclesfield, SK10 2NA, United Kingdom
| | - Kirsty Millard
- Pharmaceutical Technology & Development, AstraZeneca, Charter Way, Macclesfield, SK10 2NA, United Kingdom
| | - Alan Steven
- Pharmaceutical Technology & Development, AstraZeneca, Charter Way, Macclesfield, SK10 2NA, United Kingdom
| |
Collapse
|
6
|
Szigeti M, Dobi Z, Soós T. The Goldilocks Principle in Phase Labeling. Minimalist and Orthogonal Phase Tagging for Chromatography-Free Mitsunobu Reaction. J Org Chem 2018; 83:2869-2874. [PMID: 29378404 DOI: 10.1021/acs.joc.8b00014] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
An inexpensive and chromatography-free Mitsunobu methodology has been developed using low molecular weight and orthogonally phase-tagged reagents, a tert-butyl-tagged highly apolar phosphine, and a water-soluble DIAD analogue. The byproduct of the Mitsunobu reactions can be removed by sequential liquid-liquid extractions using traditional solvents such as hexanes, MeOH, water, and EtOAc. Owing to the orthogonal phase labeling, the spent reagents can be regenerated. This new variant of the Mitsunobu reaction promises to provide an alternative and complementary solution for the well-known separation problem of the Mitsunobu reaction without having to resort to expensive, large molecular weight reagents and chromatography.
Collapse
Affiliation(s)
- Mariann Szigeti
- Institute of Organic Chemistry, Research Centre of Natural Sciences, Hungarian Academy of Sciences Magyar tudósok körútja 2, H-1117, Budapest, Hungary
| | - Zoltán Dobi
- Institute of Organic Chemistry, Research Centre of Natural Sciences, Hungarian Academy of Sciences Magyar tudósok körútja 2, H-1117, Budapest, Hungary
| | - Tibor Soós
- Institute of Organic Chemistry, Research Centre of Natural Sciences, Hungarian Academy of Sciences Magyar tudósok körútja 2, H-1117, Budapest, Hungary
| |
Collapse
|
7
|
Deng Y, Xie Q, LaPorte MG, Chasnoff ATA, Mortensen MA, Patra D, Putrelo SA, Antonovich RS, Cao H, Yan J, Cooper AJ, Rippin SR, Alexander MD, Kumar PT, Hendi MS, Lee YH, Haimowitz T, Condon SM. Process Development and Synthesis of Birinapant: Large Scale Preparation and Acid-Mediated Dimerization of the Key Indole Intermediate. Org Process Res Dev 2016. [DOI: 10.1021/acs.oprd.5b00390] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Yijun Deng
- TetraLogic Pharmaceuticals
Corporation, 343 Phoenixville Pike, Malvern, Pennsylvania 19355, United States
| | - Qiuzhe Xie
- Albany Molecular
Research, Inc., 21 Corporate Circle, Albany, New York 12212, United States
| | - Matthew G. LaPorte
- TetraLogic Pharmaceuticals
Corporation, 343 Phoenixville Pike, Malvern, Pennsylvania 19355, United States
| | - Anna T. A. Chasnoff
- Albany Molecular
Research, Inc., 21 Corporate Circle, Albany, New York 12212, United States
| | - Mark A. Mortensen
- Albany Molecular
Research, Inc., 21 Corporate Circle, Albany, New York 12212, United States
| | - Debasis Patra
- Albany Molecular
Research, Inc., 7001 Performance Drive, North Syracuse, New York 13212, United States
| | - Seth A. Putrelo
- Albany Molecular
Research, Inc., 7001 Performance Drive, North Syracuse, New York 13212, United States
| | - Robert S. Antonovich
- Albany Molecular
Research, Inc., 21 Corporate Circle, Albany, New York 12212, United States
| | - Hong Cao
- Albany Molecular
Research, Inc., 21 Corporate Circle, Albany, New York 12212, United States
| | - Jun Yan
- Albany Molecular
Research, Inc., 21 Corporate Circle, Albany, New York 12212, United States
| | - Arthur J. Cooper
- Ricerca Biosciences, 7528 Auburn Road, Concord, Ohio 44077, United States
| | - Susan R. Rippin
- TetraLogic Pharmaceuticals
Corporation, 343 Phoenixville Pike, Malvern, Pennsylvania 19355, United States
| | - Matthew D. Alexander
- TetraLogic Pharmaceuticals
Corporation, 343 Phoenixville Pike, Malvern, Pennsylvania 19355, United States
| | - Pavan Tirunahari Kumar
- TetraLogic Pharmaceuticals
Corporation, 343 Phoenixville Pike, Malvern, Pennsylvania 19355, United States
| | - Mukta S. Hendi
- TetraLogic Pharmaceuticals
Corporation, 343 Phoenixville Pike, Malvern, Pennsylvania 19355, United States
| | - Yu-Hua Lee
- TetraLogic Pharmaceuticals
Corporation, 343 Phoenixville Pike, Malvern, Pennsylvania 19355, United States
| | - Thomas Haimowitz
- TetraLogic Pharmaceuticals
Corporation, 343 Phoenixville Pike, Malvern, Pennsylvania 19355, United States
| | - Stephen M. Condon
- TetraLogic Pharmaceuticals
Corporation, 343 Phoenixville Pike, Malvern, Pennsylvania 19355, United States
| |
Collapse
|
8
|
Colyer DE, Nortcliffe A, Wheeler S. A general synthetic strategy for 1,3-dihydro-2,1,3-benzothiadiazole 2,2-dioxides (benzosulfamides). Tetrahedron Lett 2010. [DOI: 10.1016/j.tetlet.2010.07.173] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|